Australian Pancreatic Genome Initiative Lab
The Australian Pancreatic Cancer Genome Initiative (APGI) is a global research enterprise of over 100 scientists, clinicians and allied health professionals involved in pancreatic cancer research and care.
Our mission is to improve outcomes for patients with pancreatic cancer by accelerating the translation of scientific discoveries. In a landmark effort that was part of Australia’s contribution to the International Cancer Genome Consortium (ICGC), the APGI mapped the genome of pancreatic cancer. This fundamental understanding of the genetic underpinnings of the disease is propelling treatment strategies into the molecular age of oncology. The APGI’s world-class BioResource tumour bank – which houses biological samples coupled with comprehensive clinical and genomic data – is aiding scientists worldwide in ongoing discovery and development, through quality research and strategic collaborations.